Tumor-Homing and Penetrating Peptide-Functionalized Photosensitizer-Conjugated PEG-PLA Nanoparticles for Chemo-Photodynamic Combination Therapy of Drug-Resistant Cancer

被引:54
作者
Feng, Xingye [1 ]
Jiang, Di [1 ]
Kang, Ting [1 ]
Yao, Jianhui [1 ]
Jing, Yixian [1 ]
Jiang, Tianze [1 ]
Feng, Jingxian [1 ]
Zhu, Qianqian [1 ]
Song, Qingxiang [2 ]
Dong, Nan [1 ]
Gao, Xiaoling [2 ]
Chen, Jun [1 ]
机构
[1] Fudan Univ, Sch Pharm, Key Lab Smart Drug Delivery, Minist Educ, 826 Zhangheng Rd, Shanghai 201203, Peoples R China
[2] Shanghai Jiao Tong Univ, Inst Med Sci, Dept Pharmacol, Sch Med, 280 South Chongqing Rd, Shanghai 200025, Peoples R China
基金
中国国家自然科学基金;
关键词
tumor-homing peptide; multidrug resistance; combination therapy; photodynamic therapy; nanoparticle; PHOTOCHEMICAL INTERNALIZATION; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; DELIVERY; CELLS; PACLITAXEL; NEOVASCULATURE; TARIQUIDAR; PHARMACOKINETICS; BIODISTRIBUTION;
D O I
10.1021/acsami.6b04442
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The combination of photodynamic therapy (PDT) and chemotherapy holds great potential in combating drug-resistant cancers. However, the major challenge that lies ahead is how to achieve high coloading capacity for both photosensitizer and chemo-drugs and how to gain efficient delivery of drugs to the drug-resistant tumors. In this study, we prepared a nanovehicle for codelivery of photosensitizer (pyropheophorbide-a, PPa) and chemo-drugs (paclitaxel, PTX) based on the synthesis of PPa-conjugated amphiphilic copolymer PPa-PLA-PEG-PLA-PPa. The obtained nano particles (PP NP) exhibited a satisfactory high drug-loading capacity for both drugs. To achieve effective tumor-targeting therapy, the surface of PP NP was decorated with a tumor homing and penetrating peptide F3. In vitro cellular experiments showed that F3-functionalized PP NP (F3-PP NP) exhibited higher cellular association than PP NP and resulted in the strongest antiproliferation effect. In addition, compared with the unmodified nanoparticles, F3-PP NP exhibited a more preferential enrichment at the tumor site. Pharmacodynamics evaluation in vivo demonstrated that a longer survival time was achieved by the tumor-bearing mice treated with PP NP (+laser) than those treated with chemotherapy only or PDT only. Such antitumor efficacy of combination therapy was further improved following the F3 peptide functionalization. Collectively, these results suggested that targeted combination therapy may pave a promising way for the therapy of drug-resistant tumor.
引用
收藏
页码:17817 / 17832
页数:16
相关论文
共 42 条
  • [1] Factors affecting the clearance and biodistribution of polymeric nanoparticles
    Alexis, Frank
    Pridgen, Eric
    Molnar, Linda K.
    Farokhzad, Omid C.
    [J]. MOLECULAR PHARMACEUTICS, 2008, 5 (04) : 505 - 515
  • [2] Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
    Aller, Stephen G.
    Yu, Jodie
    Ward, Andrew
    Weng, Yue
    Chittaboina, Srinivas
    Zhuo, Rupeng
    Harrell, Patina M.
    Trinh, Yenphuong T.
    Zhang, Qinghai
    Urbatsch, Ina L.
    Chang, Geoffrey
    [J]. SCIENCE, 2009, 323 (5922) : 1718 - 1722
  • [3] Avgoustakis Konstantinos, 2004, Current Drug Delivery, V1, P321, DOI 10.2174/1567201043334605
  • [4] Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer
    Bai, Fan
    Wang, Chao
    Lu, Qin
    Zhao, Mei
    Ban, Fu-Qiang
    Yu, De-Hong
    Guan, Ying-Yun
    Luan, Xin
    Liu, Ya-Rong
    Chen, Hong-Zhuan
    Fang, Chao
    [J]. BIOMATERIALS, 2013, 34 (26) : 6163 - 6174
  • [5] Site-specific drug delivery by photochemical internalization enhances the antitumor effect of bleomycin
    Berg, K
    Dietze, A
    Kaalhus, O
    Hogset, A
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (23) : 8476 - 8485
  • [6] Targeted Imaging and Therapy of Brain Cancer Using Theranostic Nanoparticles
    Bhojani, Mahaveer Swaroop
    Van Dort, Marcian
    Rehemtulla, Alnawaz
    Ross, Brian D.
    [J]. MOLECULAR PHARMACEUTICS, 2010, 7 (06) : 1921 - 1929
  • [7] The present and future role of photodynamic therapy in cancer treatment
    Brown, SB
    Brown, EA
    Walker, I
    [J]. LANCET ONCOLOGY, 2004, 5 (08) : 497 - 508
  • [8] Chen Bin, 2005, Expert Opin Drug Deliv, V2, P477, DOI 10.1517/17425247.2.3.477
  • [9] Preclinical versus clinical drug combination studies
    Chou, Ting-Chao
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (11) : 2059 - 2080
  • [10] Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels
    Christian, S
    Pilch, J
    Akerman, ME
    Porkka, K
    Laakkonen, P
    Ruoslahti, E
    [J]. JOURNAL OF CELL BIOLOGY, 2003, 163 (04) : 871 - 878